BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 32930705)

  • 1. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
    Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.
    Rao K; Micic D; Natarajan M; Winters S; Kiel MJ; Walk ST; Santhosh K; Mogle JA; Galecki AT; LeBar W; Higgins PD; Young VB; Aronoff DM
    Clin Infect Dis; 2015 Jul; 61(2):233-41. PubMed ID: 25828993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of Clostridioides difficile PCR ribotype 181 in northern Greece, 2016-2019.
    Kachrimanidou M; Metallidis S; Tsachouridou O; Harmanus C; Lola V; Protonotariou E; Skoura L; Kuijper E
    Anaerobe; 2022 Aug; 76():102601. PubMed ID: 35688364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
    Perry MD; White PL; Morris TE
    Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
    Miller R; Morillas JA; Brizendine KD; Fraser TG
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016.
    Snydman DR; McDermott LA; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Thorpe CM; Walk ST
    Anaerobe; 2020 Jun; 63():102185. PubMed ID: 32387171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Clostridium difficile ribotype 027 in Korea.
    Kim H; Lee Y; Moon HW; Lim CS; Lee K; Chong Y
    Korean J Lab Med; 2011 Jul; 31(3):191-6. PubMed ID: 21779194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study.
    Leis JA; Gold WL; Ng J; Hirji Z; Pillai DR; Broukhanski G; Raggiunti P; Hota S; McGeer A; Poutanen SM
    BMC Infect Dis; 2013 Jul; 13():324. PubMed ID: 23865713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
    Mah R; Locher K; Steiner TS; Stefanovic A
    Anaerobe; 2023 Aug; 82():102755. PubMed ID: 37406762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
    Yepez Guevara EA; Aitken SL; Olvera AV; Carlin L; Fernandes KE; Bhatti MM; Garey KW; Adachi J; Okhuysen PC
    Clin Infect Dis; 2021 May; 72(10):e460-e465. PubMed ID: 32803229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan.
    Chang FC; Liu CP; Sun FJ; Lin CC
    J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality.
    Boone JH; Archbald-Pannone LR; Wickham KN; Carman RJ; Guerrant RL; Franck CT; Lyerly DM
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):1045-51. PubMed ID: 24449345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.
    Al-Thani AA; Hamdi WS; Al-Ansari NA; Doiphode SH; Wilson GJ
    BMC Infect Dis; 2014 Sep; 14():502. PubMed ID: 25223337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of
    Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
    Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
    J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.